David Blumberg is the Managing Partner of Blumberg Capital. David has been investing in early stage technology companies for more than 24 years. His current investment focus includes Digital Media, Social Media, Mobility, SaaS/Technology Enabled Services and Internet.
Prior to founding Blumberg Capital in 1991, David managed technology investments with Claridge Investments, Adler & Co., Apax, and T. Rowe Price Associates. David launched the business development efforts for Check Point Software Technologies.
David earned his AB in Government, cum laude, from Harvard College and his MBA from the Stanford Graduate School of Business and INSEAD. David speaks French and is proficient in Hebrew and Spanish.
David serves as a member or observer on the Board of Directors of CaseStack, DoubleVerify, Siperian, Correlix, and isocket. He is a member of the Pacific Council on International Policy.
Past Investments: Check Point Software Technologies [CHKP], Teva [TEVA], Creo - Acquired by, Eastman Kodak [EK], DSP Group [DSPG], Electronics For Imaging [EFII], AbirNet - Acquired by Computer Associates [CA], Conduct Software - Acquired by Hewlett Packard [HPQ], Allerez - Acquired by Hewlett Packard [HPQ], Vista Research - Acquired by McGraw Hill [MHP], IP Infusion - Acquired by ACCESS Co., Ltd. [TSE:4513]
| Company | Date | Round | Size | Participants |
| isocket | 9/11 | Series A | 4 |
